Glucose sensor (CRP/cAMP + CRISPRi)

Reports glucose via catabolite repression (CRP/cAMP). When glucose is low, cAMP-CRP activates its promoters; when glucose is high, it switches off. CRP gates a CRISPRi circuit driving a fluorescent reporter, in the probiotic E. coli Nissle 1917 — relevant to gut/metabolic monitoring.

Clinical / gut biomarkerBSL-1 chassistemplateclinical-gutglucosemetaboliccatabolite-repressionprobioticNissleCRISPRi
Input
Glucose
Clinical / gut biomarker
Sense
CRISPRi-repression
dCas9 (S. pyogenes, catalytically dead)
Chassis
E. coli Nissle 1917
BSL-1
Output
sfGFP
fluorescent

What it detects

Analyte
Glucose — CRP/cAMP responds across the glucose-rich to -poor transition
Category
Clinical / gut biomarker
Signal
Glucose availability via the cAMP-CRP catabolite-repression system

Genetic circuit

⤢ click to enlarge

Genetic construct (SBOL)

The DNA construct as transcription units, drawn with SBOL Visual part glyphs.

⤢ click to enlarge

CRISPR sensing mechanism

Strategy
CRISPRi-repression · NOT logic
Cas protein
dCas9 (S. pyogenes, catalytically dead)
Analyte sensor
Low glucose raises cAMP, which binds CRP to activate CRP-dependent promoters; high glucose lowers cAMP and switches them off.
Signal flow
Glucose change -> cAMP-CRP activity at Pcrp -> transcribes an sgRNA -> CRISPRi inverts a constitutive reporter (NOT). Net: reporter tracks glucose (via the CRP inversion); choose inverter polarity for the desired direction.

Safe chassis

E. coli Nissle 1917Escherichia coli

A probiotic E. coli used in humans for over a century (Mutaflor). Colonizes the gut safely, making it the chassis of choice for clinical / gut biomarker biosensors.

BSL-1probiotic

Genetic parts

PartRoleSource / id
CRP (cAMP receptor protein)
Glucose/catabolite-state sensor; endogenous to E. coli Nissle.
regulatorNative E. coli crp / cya (cAMP)
CRP-dependent promoter
Active at low glucose (high cAMP-CRP).
promoterE. coli CRP-activated promoter (e.g. derived from lac/cat)
sgRNAsgRNAdesigned against the reporter promoter
sgRNA scaffold (SpCas9)
GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGC
sgRNAStandard SpCas9 scaffold
dCas9dCas9Qi et al. 2013 (CRISPRi)
sfGFP reporter
Recoverable from stool for non-invasive readout.
reporterPedelacq et al. 2006

Output & readout

Type
fluorescent
Reporter
sfGFP
Readout
Fluorescence (flow cytometry on recovered cells)
Positive result
Signal tracks glucose availability (via the CRP/CRISPRi inversion).

Performance

Limit of detection
CRP/cAMP reports the glucose-rich to -poor transition (module-validated).
Dynamic range
Glucose-replete to -limited transition
Response time
~150 min
Device validated
No — design template (parts validated individually)

An indirect, relative glucose readout via catabolite repression; CRP and CRISPRi are validated separately and integration is a design template.

Safety

Biosafety level
BSL-1 (non-pathogenic chassis)
GRAS chassis
No
Biocontainment
Probiotic E. coli Nissle host; add thyA/dapA auxotrophy for gut-restricted containment.
Field-deployable
Lab / supervised use

Probiotic chassis with a human-safety record; research / supervised clinical use only.

Build & run

#StageStep
1designDesign sgRNA + choose polarity
Target the reporter promoter; pick inverter polarity for the desired glucose direction.
2assemblyAssemble units
TU1: CRP-dependent promoter -> sgRNA (native CRP/cAMP). TU2: dCas9 + reporter. Low-copy vector.
3transformationTransform E. coli Nissle 1917
Select; add auxotrophic containment.
4inductionValidate in vitro
Confirm response across a glucose series before any animal work.
5readoutRecover and measure
Recover cells from stool; quantify fluorescence.

Source & parts

Design
Design template combining the native E. coli CRP/cAMP catabolite system with a dCas9 CRISPRi circuit in E. coli Nissle
Parts validated in
  • Busby & Ebright / CRP-cAMP catabolite repression (E. coli)
  • Qi et al. 2013, Cell (CRISPRi)
License
Parts per their original sources; design template CC BY 4.0